BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29806866)

  • 1. Near final height in patients with idiopathic growth hormone deficiency: A single-centre experience.
    Kurnaz E; Çetinkaya S; Aycan Z
    J Paediatr Child Health; 2018 Nov; 54(11):1221-1226. PubMed ID: 29806866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F; Lindberg A; Wilton P
    Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies.
    Maghnie M; Ambrosini L; Cappa M; Pozzobon G; Ghizzoni L; Ubertini MG; di Iorgi N; Tinelli C; Pilia S; Chiumello G; Lorini R; Loche S
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2900-5. PubMed ID: 16684828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Final Adult Height and Its Determinants in Patients with Growth Hormone Deficiency: A Single-centre Experience from the South-Eastern Region of Turkey.
    Demiral M; Unal E; Baysal B; Baran RT; Demirbilek H; Özbek MN
    J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):295-302. PubMed ID: 32157854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth response, pubertal growth and final height in Greek children with growth hormone (GH) deficiency on long-term GH therapy and factors affecting outcome.
    Karavanaki K; Kontaxaki C; Maniati-Christidi M; Petrou V; Dacou-Voutetakis C
    J Pediatr Endocrinol Metab; 2001 Apr; 14(4):397-405. PubMed ID: 11327373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to growth hormone with respect to pubertal status on increased dose in idiopathic growth hormone deficiency: an analysis of Turkish children in the KIGS database (Pfizer International Growth Study).
    Darendeliler F; Berberoğlu M; Ocal G; Adiyaman P; Bundak R; Günöz H; Baş F; Darcan S; Gökşen D; Arslanoğlu I; Yildiz M; Ercan O; Ercan G; Ozerkan E; Can S; Böber E; Adal E; Sarikaya S; Dallar Y; Siklar Z; Bircan I; Bideci A; Yüksel B; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2005 Oct; 18(10):949-54. PubMed ID: 16355808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board.
    Cutfield W; Lindberg A; Albertsson Wikland K; Chatelain P; Ranke MB; Wilton P
    Acta Paediatr Suppl; 1999 Feb; 88(428):72-5. PubMed ID: 10102057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database.
    Reiter EO; Price DA; Wilton P; Albertsson-Wikland K; Ranke MB
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2047-54. PubMed ID: 16537676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final height in children with idiopathic growth hormone deficiency treated with recombinant human growth hormone: the Belgian experience.
    Thomas M; Massa G; Bourguignon JP; Craen M; De Schepper J; de Zegher F; Dooms L; Du Caju M; François I; Heinrichs C; Malvaux P; Rooman R; Thiry-Counson G; Vandeweghe M; Maes M
    Horm Res; 2001; 55(2):88-94. PubMed ID: 11509865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prepubertal children with growth hormone deficiency treated for four years with growth hormone experience dose-dependent increase in height, but not in the rate of puberty initiation.
    Rogol AD; Cohen P; Weng W; Kappelgaard AM; Germak JA
    Horm Res Paediatr; 2013; 80(1):28-37. PubMed ID: 23816571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study.
    Ranke MB; Price DA; Albertsson-Wikland K; Maes M; Lindberg A
    Horm Res; 1997; 48(2):62-71. PubMed ID: 9251922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final height in growth hormone-deficient childhood cancer survivors after growth hormone therapy.
    Rodari G; Cattoni A; Albanese A
    J Endocrinol Invest; 2020 Feb; 43(2):209-217. PubMed ID: 31452114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final height of patients treated for isolated GH deficiency: examination of 83 patients.
    Cacciari E; Cicognani A; Pirazzoli P; Zucchini S; Salardi S; Balsamo A; Cassio A; Pasini A; Carlá G; Tassinari D; Gualandi S
    Eur J Endocrinol; 1997 Jul; 137(1):53-60. PubMed ID: 9242202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter EO; Lindberg A; Ranke MB; Price DA; Albertsson-Wikland K; Cowell CT; Bakker B
    Horm Res; 2003; 60(Suppl 1):68-73. PubMed ID: 12955021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
    Rachmiel M; Rota V; Atenafu E; Daneman D; Hamilton J
    Horm Res; 2007; 68(5):236-43. PubMed ID: 17396034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of bone age maturation and growth velocity in isolated growth hormone (GH) deficient boys with and without gonadal suppression treatment and in GH deficient boys with associated gonadotropin deficiency.
    Satoh M; Tanaka T; Hibi I
    J Pediatr Endocrinol Metab; 1997; 10(6):615-22. PubMed ID: 9467132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.